Related Experiment Video
Updated: Jun 5, 2026

Production and Testing of Antimicrobial Peptides and Their Mimics
Published on: April 10, 2026
Structure-Activity Relationship Study of Antimicrobial Peptide with Cross-Kingdom Activity
Aparna Palakkurussi Rathessan1, Fereshteh Ghazisaeedi2,3, Krithika Unmesh4
1Institute of Chemistry and Biochemistry, Freie Universität Berlin, Berlin 14195, Germany.
Novel antimicrobial peptides (AMPs) were engineered to combat antibiotic resistance. Modifications improved resistance to enzymatic degradation while retaining antimicrobial activity, offering new strategies against resistant pathogens.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Microbiology
Background:
- Antibiotic-resistant pathogens present a critical global health threat, necessitating novel antimicrobial discovery approaches.
- Antimicrobial peptides (AMPs) show promise due to broad-spectrum activity, including against multidrug-resistant strains.
- The SAJO-2 peptide, with a unique d-Phe-2-Abz unit, was previously enhanced via fluorination, increasing potency but also enzymatic susceptibility.
Purpose of the Study:
- To enhance the efficacy and stability of the SAJO-2 antimicrobial peptide.
- To overcome limitations of previous modifications, specifically increased susceptibility to enzymatic digestion.
- To develop novel AMPs with improved resistance to degradation and retained antimicrobial activity.
Main Methods:
- Incorporation of D-amino acids into the peptide backbone.
- Introduction of beta backbone modifications.
- Inclusion of a bulky pentafluorinated amino acid residue.
Main Results:
- All modified SAJO-2 peptides demonstrated resistance to enzymatic degradation by β-trypsin.
- Antimicrobial activity was preserved to varying extents across different microbial organisms.
- The modifications successfully addressed the enzymatic instability issue encountered in prior fluorinated analogs.
Conclusions:
- Engineered SAJO-2 analogs exhibit enhanced stability against enzymatic breakdown.
- These modified AMPs represent a promising avenue for developing new therapeutics against antibiotic-resistant bacteria.
- Further research can optimize these modifications for broad clinical application in combating infectious diseases.
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antimicrobial Effectiveness
Clinical Significance of Antibiotic Resistance
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Inhibitors of Gram-positive Cell Wall Synthesis
